Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Change In Payables And Accrued Expense : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Tonghua Dongbao Pharmaceutical Co Change In Payables And Accrued Expense?

Tonghua Dongbao Pharmaceutical Co's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Tonghua Dongbao Pharmaceutical Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Mar. 2024 .

Tonghua Dongbao Pharmaceutical Co's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was ¥0 Mil. It means Tonghua Dongbao Pharmaceutical Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

Tonghua Dongbao Pharmaceutical Co Change In Payables And Accrued Expense Historical Data

The historical data trend for Tonghua Dongbao Pharmaceutical Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tonghua Dongbao Pharmaceutical Co Change In Payables And Accrued Expense Chart

Tonghua Dongbao Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Tonghua Dongbao Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Tonghua Dongbao Pharmaceutical Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Tonghua Dongbao Pharmaceutical Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Tonghua Dongbao Pharmaceutical Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) » Definitions » Change In Payables And Accrued Expense

Traded in Other Exchanges

N/A

Address

Dongbao Village, Jilin Province, Tonghua, CHN, 134123

Website

http://www.thdb.com

Tonghua Dongbao Pharmaceutical Co Ltd is a China-based firm. Its engaged in the production and distribution of pharmaceutical products. Its products include human insulin injection, Heart and brain capsule, Vitamin e soft capsule, and Oral detoxification products.

Executives

Cheng Jian Qiu	Supervisors
Chang Xiao Hui	Director
Li Cong	Director
Li Feng Qin	Director
Chen Hong	senior management
Leng Chun Sheng	Director
Li Yi Kui	Director
Wang Dian Duo	Supervisors
Wang Jun Ye	Director
Han Jie	Director

Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Headlines

No Headlines